Skip to main content
SpringerLink
Log in
Book cover

Manual for the Planning and Implementation of Therapeutic Studies pp 89–100Cite as

References

  • Conference paper

  • 22 Accesses

Part of the book series: Lecture Notes in Medical Informatics ((LNMED,volume 20))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

Chapter 1

  • Althauser, R.P., D.B. Rubin: The computerized construction of a matched sample. American Journal of Sociology 76 (1970) 325–346

    Article  Google Scholar 

  • Armitage, P.: Restricted sequential procedures. Biometrica 44 (1957) 9–26

    MathSciNet  MATH  Google Scholar 

  • Armitage, P.: Statistical methods in medical research. Oxford: Black-well 1971

    Google Scholar 

  • Armitage/ P.: Sequential medical trials, 2nd edition. Oxford: Black-well 1975

    Google Scholar 

  • Atkins, H.: Controlled trials. British Medical Journal 1 (1966) 1101–1109

    Google Scholar 

  • Boston Collaborative Drug Surveillance Program: Regular aspirin intake and acute myocardial infarction. British Medical Journal 1 (1974) 440–443

    Article  Google Scholar 

  • Breslow, N.E.: Regression analysis of the odds ratio: A method for retrospective studies. Biometrics 32 (1976) 409–416

    Article  MathSciNet  MATH  Google Scholar 

  • Breslow, N.E., N.E. Day, K.T. Halvorsen, R.L. Prentice, C. Sabai: Estimation of multiple relative risk functions in machted case-control-studies. American Journal of Epidemiology 108 (1978) 299–307

    Google Scholar 

  • Bross, I.: Sequential medical plans. Biometrics 8 (1952) 188–205

    Article  Google Scholar 

  • Bross, I.: Misclassification in 2 × 2 tables. Biometrics 9 (1954) 478–486

    Article  MathSciNet  Google Scholar 

  • Bross, I.: How case-for-case matching can improve design efficiency. American Journal of Epidemiology 89 (1969) 359–363

    Google Scholar 

  • Cochran, W.G.: Matching in analytical studies. American Journal of Public Health 43 (1953) 684–691

    Article  Google Scholar 

  • Cochran, W.G.: The planning of observational studies in human populations. Journal of the Royal Statistical Society, Series A 128 (1965) 234–266

    Article  Google Scholar 

  • Cochran, W.G.: Sampling techniques, 2nd edition. New York, London: Wiley 1963

    Google Scholar 

  • Cochran, W.G., G.M. Cox: Experimental designs, 2nd edition. New York, London, Sidney: Wiley 1957

    MATH  Google Scholar 

  • Cornfield, J.: A statistical problem arising from retrospective studies. Proceedings of the Third Berkeley Symposium 4 (1956) 135–148

    MathSciNet  Google Scholar 

  • Cornfield, J.: Recent methodological contributions to clinical trials. American Journal of Epidemiology 104 (1976) 408–421

    Google Scholar 

  • Cornfield, J., W. Haenszel: Some aspects of retrospective studies. Journal of Chronic Diseases 11 (1960) 523–534

    Article  Google Scholar 

  • Feinstein, A.R.: Clinical biostatistics: The epidemiologic trohoc, the relative risk ratio, and retrospective research. Clinical Pharmacology and Therapeutics 14 (1973) 291–307

    Google Scholar 

  • Fink, H.: Grundsätze des kontrollierten Versuchs. Arzneimittelforschung/ Drug Research 28 (1978) 2017–2019

    Google Scholar 

  • Fischer, L., K. Patil: Matching and unirelatedness. American Journal of Epidemiology 100 (1974) 347–349

    Google Scholar 

  • Freedman, R.: Incomplete matching in ex-post facto studies. American Journal of Sociology 55 (1950) 485–487

    Article  Google Scholar 

  • Friebel, H.: Langzeitversuch und Langzeiterfahrung in der angewandten Therapie (Phase IV). In: K.W. Eickstedt, F. Gross (Hrsg.): Klinische Arzneimittelprüfung. Stuttgart: Gustav Fischer 1975, 145–151

    Google Scholar 

  • Gehan, E.A., E.J. Freireich: Non-randomized controls in cancer clinical trials. New England Journal of Medicine 290 (1974) 198–203

    Article  Google Scholar 

  • Gordis, L.: Assuring the quality of questionnaire data in epidemiologic research. American Journal of Epidemiology 109 (1979) 21–24

    Google Scholar 

  • Gordon, T., F.E. Moore, D. Shurtleff, T.R. Dawber: Some methodologic problems in the longterm-study of cardiovascular disease: Observations in the Framingham Study. Journal of Chronic Diseases 10 (1959) 186–206

    Article  Google Scholar 

  • Greenland, S.: Response and follow-up bias in cohort studies. American Journal of Epidemiology 106 (1977) 184–187

    Google Scholar 

  • Gross, F.H., W.H.W. Inman (Eds.): Drug monitoring. New York, London: Academic Press 1977

    Google Scholar 

  • Hardy, R.H., C. White: Matching in retrospective studies. American Journal of Epidemiology 93 (1971) 75

    Google Scholar 

  • Harris, E.L., J.D. Fitzgerald (Eds.): The principles and practice of clinical trials. Edinburgh, London: Livingstone 1970

    Google Scholar 

  • Hill, A.B.: The principles of medical statistics. 8th edition. London: Lancet 1966

    Google Scholar 

  • Hölzel, D., K. Überla: Grundsätze der Versuchsplanung. In: H.P. Kümmerle (Hrsg.): Methoden der klinischen Pharmakologie. München: Urban & Schearzenberg 1978, 37–57

    Google Scholar 

  • Holford, T.R., C. White, J.L. Kelsey: Multivariate analysis for matched case-control-studies. American Journal of Epidemiology 107 (1978) 245–256

    Google Scholar 

  • Imhof, P.R.: Erwünschte und unerwünschte Wirkungen von Prüfpräparaten bei Phase-I-Studien. Arzneimittelforschung/Drug Research 23 (1973) 1147–1152

    Google Scholar 

  • Jesdinsky, H.J. (Hrsg.): Memorandum zur Planung und Durchführung kontrollierter klinischer Therapiestudien, Schriftenreihe der GMDS, No. 1, Stuttgart: Schattauer 1978

    Google Scholar 

  • Jesdinsky, H.J.: Planung einer Studie. In: G. Füllgraf, H. Kewitz (Hrsg.): Arzneimittelprüfung durch den niedergelassenen Arzt. Stuttgart: Gustav Fischer 1979, 44–59

    Google Scholar 

  • Jick, H.: The discovery of drug induced illness. New England Journal of Medicine 296 (1977) 481–485

    Article  Google Scholar 

  • Jick, H., M.P. Vessey: Case-control studies in the evaluation of drug induced illness. American Journal of Epidemiology 107 (1978) 1–7

    Google Scholar 

  • Kleinsorge, H.: Problematik der Bewertung experimenteller Voruntersuchungen für die klinische Prüfung neuer Pharmaka. Arzneimittelforschung/ Drug Research 25 (1975) 1112–1118

    Google Scholar 

  • Koller, S.: Auswertung. In: S. Koller, G. Wagner (Hrsg.): Handbuch der medizinischen Dokumentation und Datenverarbeitung. Stuttgart: Schattauer 1975, 289–317

    Google Scholar 

  • Lindley, D.V.: Making decisions. New York, London: Wiley 1975

    Google Scholar 

  • Mantel, N., W. Haenszel: Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 22 (1959) 719–748

    Google Scholar 

  • McKinlay, S.M.: Pair-matching — A reappraisal of a popular technique. Biometrics 33 (1977) 725–735

    Article  Google Scholar 

  • McKinlay, S.M.: The design and analysis of the observational study: A review. Journal of the American Statistical Association 70 (1975) 503–520

    Article  MATH  Google Scholar 

  • McKinlay, S.M.: The expected number of matches and its variance, for matched pair designs. Applied Statistics 23 (1974) 372–383

    Article  Google Scholar 

  • MacMahon, B., T.F. Pugh: Epidemiology: Principles and Methods. Boston, Mass.: Little Brown and Company 1970

    Google Scholar 

  • Meier, P.: Statistics and medical experimentation. Biometrics 31 (1975) 511–529

    Article  MATH  Google Scholar 

  • Meydrech, E.F., L.L. Kupper: Cost considerations and sample size requirements in cohort and case control studies. American Journal of Epidemiology 107 (1978) 201–205

    Google Scholar 

  • Miettinen, O.S.: The matched pairs design in the case of all-or-none response. Biometrics 24 (1968) 339–352

    Article  MathSciNet  Google Scholar 

  • Miettinen, O.S.: Individual matching with multiple controls in the case of all-or-none response. Biometrics 25 (1969) 339–355

    Article  MathSciNet  Google Scholar 

  • Miettinen, O.S.: Estimation of relative risk from individually matched series. Biometrics 26 (1970) 75–86

    Article  Google Scholar 

  • Miettinen, O.S.: Estimability and estimation in case-referent studies. American Journal of Epidemiology 103 (1976) 226–235

    Google Scholar 

  • O’Neil, R.T., C. Anello: Case-control-studies: A sequential approach. American Journal of Epidemiology 108 (1978) 415–424

    Google Scholar 

  • Nüssel, E., F.-J. Hehl, R. Scola: Die Gesamtkonzeption der epidemiologischen Herzinfarktforschung in Heidelberg. Medizinische Technik 95 (1975) 109–112

    Google Scholar 

  • Peto, R., M.C. Pike, P. Armitage, N.E. Breslow, D.R. Cox, S.V. Howard, N. Mantel, K. McPershon, J. Peto, P.G. Smith: Design and analysis of randomized clinical trials requiring prolonged observation of each patient, Part I. British Journal of Cancer 34 (1976) 585–612;

    Article  Google Scholar 

  • Peto, R., M.C. Pike, P. Armitage, N.E. Breslow, D.R. Cox, S.V. Howard, N. Mantel, K. McPershon, J. Peto, P.G. Smith: Design and analysis of randomized clinical trials requiring prolonged observation of each patient, Part II: British Journal of Cancer 35 (1977) 1–39

    Article  Google Scholar 

  • Pike, M.C., J. Casagrande, P.G. Smith: Statistical analysis of individually matched case-control studies in epidemiology: Factor under study a discrete variable taking multiple values, British Journal of Preventive and Social Medicine 29 (1975) 196–201

    Google Scholar 

  • Pocock, S.J.: Group sequential methods in the design and analysis of clinical trials. Biometrica 64 (1977) 191–199

    Article  Google Scholar 

  • Prentice, R.: Use of the logistic model in retrospective studies. Biometrics 32 (1976) 599–607

    Article  MATH  Google Scholar 

  • Raiffa, H.: Decision analysis: Introductory lectures on choices under uncertainty. Reading, Mass.: Eddison Wesley 1968

    MATH  Google Scholar 

  • Schlesselman, J.J.: Sample size requirements in cohort and case-control studies of disease. American Journal of Epidemiology 99 (1974) 381–384

    Google Scholar 

  • Seigel, D.H., S.W. Greenhouse: Multiple relative risk functions in case-control studies. American Journal of Epidemiolocry 97 (1973) 324–331

    Google Scholar 

  • Selbmann, H.K.: Grenzen und methodische Schwierigkeiten bei multizentrischen Studien. Arzneimittelforschung/Drug Research 28 (1978) 2023–2026

    Google Scholar 

  • Shapiro, S., D. Slone: Case-control surveillance. In: F.H. Gross, W.H.W. Inman (Eds.): Drug monitoring. London, New York: Academic Press, 1977

    Google Scholar 

  • Staak, M., A. Weiser: Klinische Prüfung von Arzneimitteln. Methodik und Rechtsgrundlagen. Stuttgart: Enke 1978

    Google Scholar 

  • Susser, M.: Causal thinking in health sciences: Concepts and strategies in epidemiology. New York: Oxford University Press 1973

    Google Scholar 

  • Susser, M.: Judgement and causal inference: criteria in epidemiologic studies. American Journal of Epidemiology 105 (1977) 1–15

    Google Scholar 

  • Überla, K.: Versuchsplanung und Statistik in Phase II und III. Arzneimittelf orschung/Drug Research 23 (1973) 1192–1196

    Google Scholar 

  • Überla, K.: Die biometrische Planung und Auswertung klinischer Prüfungen. In: K.W. v. Eickstedt, F. Gross (Hrsg.): Klinische Arzneimittelprüfung. Stuttgart: Gustav Fischer 1975, 137–144

    Google Scholar 

  • Überla, K.: Versuchsplanung in Phase I. Arzneimittelforschung/Drug Research 28 (1978) 2032–2036

    Google Scholar 

  • Walter, S.D.: Determination of significant relative risks and optimal sampling procedures in prospective and retrospective comparative studies of various sizes. American Journal of Epidemiology 105 (1977) 387–397

    Google Scholar 

  • Wolf, H.P.: Klinisch -chemische Untersuchungen in Phase I der Arzneimittelprüfung am Menschen. Arzneimittelforschung/Drug Research 25 (1975) 1124–1126

    Google Scholar 

  • Worcester, J.: Matched samples in epidemiologic studies. Biometrics 20 (1964) 840–848

    Article  Google Scholar 

Chapter 2

  • Ambler, S.: Statistical analysis of clinical trial data. In: F.N. Johnson, S. Johnson (Eds.): Clinical Trials. Oxford: Blackwell 1977, 83–107

    Google Scholar 

  • Ermitage, P.: Sequential medical trials. Oxford: Blackwell 1975

    Google Scholar 

  • Bearman, J.E.: Writing the protocol for a clinical trial. American Journal of Ophtalmology 79 (1975) 775–778

    Google Scholar 

  • Bennet, A.E., K. Ritchie: Questionnaires in medicine — A guide to their design and use. London: Oxford University Press 1975

    Google Scholar 

  • Bentel, P., H. Kuffner, E. Röck, W. Schubö: SPSS — Statistik Programmsystem für die Sozialwissenschafren nach NIE, HULL, JENKINS, STEINBRENNER, BENT. Stuttgart: Gustav Fischer 1980

    Google Scholar 

  • Berdie, D.R., J.F. Anderson: Questionnaires, design and use. Metuchen, N.Y.: Scarecrow Press 1974

    Google Scholar 

  • Berger, P.M., R.A. Stallones: Legal Liability and epidemiologic research. American Journal of Epidemiology 106 (1977) 177–183

    Google Scholar 

  • Breslow, N.: Perspectives on the statistician’s role in cooperative clinical research. Cancer 41 (1978) 326–332

    Article  Google Scholar 

  • Bross, I.D.J.: Sequential medical plans. Biometrics 8 (1952) 188–205

    Article  Google Scholar 

  • Bulpitt, C.J.: The design of clinical trials. British Journal of Hospital Medicine 13 (1975) 611–680

    Google Scholar 

  • Burley, D.M.: Designing the correct protocol. In: C.S. Good (Ed.): The principles and practice of clinical trials. Edinburgh: Churchill Livingstone 1976

    Google Scholar 

  • Byar, D.P., R.M. Simon, W.T. Friedewald, J.J. Schlesselman, D.L. De Mets, J.H. Ellenberg, M.H. Gail, J.H. Ware: Randomized clinical trials. New England Journal of Medicine 295 (1976) 74–80

    Article  Google Scholar 

  • Carter, S.K.: Clinical trials in cancer chemotherapy. Cancer 40 (1977) 544–557

    Article  Google Scholar 

  • Chalmers, T.C., J.B. Block, S. Lee: Controlled studies in clinical cancer research. New England Journal of Medicine 287 (1972) 75–78

    Article  Google Scholar 

  • Clark, C.J., C.C. Downie: A method for the rapid determination of the number of patients to include in a controlled clinical trial. Lancet 2 (1966) 1357–1358

    Article  Google Scholar 

  • Cornfield, J.: Recent methodological contributions to clinical trials. American Journal of Epidemiology 104 (1976) 408–421

    Google Scholar 

  • Cranston, W.I., G.E. Sowton, J.D. Fitzgerald: Cardiovascular drug evaluation. In: E.L. Harris, J.D. Fitzgerald (Eds.): The principles and practice of clinical trials. London, Edinburgh: Livingstone 1970, 134–164

    Google Scholar 

  • Daniel, G.R., M. Shephard, M. Hamilton: Evaluation of psychotropic drugs. In: E.L. Harris, J.D. Fitzgerald (Eds.): The principles and practice of clinical trials. London, Edinburgh: Livingstone 1970, 189–226

    Google Scholar 

  • Deeley, T.J.: The random allocation of patients in clinical trials. Methods of Information in Medicine 5 (1966) 100–101

    Google Scholar 

  • Dixon, W.J. (Ed.): BMDP Biomedical computer programs. Berkeley: Universtiy of California Press 1981

    Google Scholar 

  • Documenta Geigy: Wissenschaftliche Tabellen. Stuttgart: Thieme 1975

    Google Scholar 

  • Ederer, P.: Practical problems in collaborative clinical trials. American Journal of Epidemiology 102 (1975) 111–118

    Google Scholar 

  • von Eickstedt, K.W., F. Gross (Hrsg.): Klinische Arzneimittelprüfung. Stuttgart: Gustav Fischer 1975

    Google Scholar 

  • van Eimeren, W., K. Überla: Thesen zu Problemen des Arzneimittelrechts aus statistischer und methodischer Sicht. Pharma Dialog 36 (1975) 3–17

    Google Scholar 

  • Feinstein, A.R.: Clinical biostatistics. Saint Louis: Mosby Company 1977

    Google Scholar 

  • Feinstein, A.R.: Clinical biostatistics XXII — XXIV, The role of randomization in sampling, testing, allocation, and credulous idolatry, Clinical Pharmacology and Therapeutics 14 (1973) 601–615,

    Google Scholar 

  • Feinstein, A.R.: Clinical biostatistics XXII — XXIV, The role of randomization in sampling, testing, allocation, and credulous idolatry, Clinical Pharmacology and Therapeutics 14 (1973) 898–915,

    Google Scholar 

  • Feinstein, A.R.: Clinical biostatistics XXII — XXIV, The role of randomization in sampling, testing, allocation, and credulous idolatry, Clinical Pharmacology and Therapeutics 14 (1973) 1035–1051

    Google Scholar 

  • Feinstein, A.R., J.R. Landis: The role of prognostic stratification in preventing the bias permitted by random allocation of treatment. Journal of Chronic Diseases 29 (1976) 277–284

    Article  Google Scholar 

  • Fink, H.: Zur Frage der Zahl der Probanden oder Patienten in klinisch-pharmakologischen Studien. International Journal of Clinical Pharmacology 14 (1976) 66–74

    Google Scholar 

  • Flamant, R. (Ed.): Controlled therapeutic trials in cancer. UICC Technical Report Series, Vol. 8. Genf.: UICC 1972

    Google Scholar 

  • Fülgraff, G., H. Kewitz (Hrsg.): Arzneimittelprüfung durch den niedergelassenen Arzt. Stuttgart: Gustav Fischer 1979

    Google Scholar 

  • Galbraith, A.W.: Getting the trial off the ground: logistics, presentation of supplies. In: C.S. Good (Ed.): The principles and practice of clinical trials. Edinburgh: Livingstone 1976, 101–106

    Google Scholar 

  • Gehan, E.A., E.J. Freireich: Non-randomized controls in cancer clinical trials. New England Journal of Medicine 290 (1974) 198–203

    Article  Google Scholar 

  • George, S.L., M.M. Desu: Planning the size and duration of a clinical trial studying the time to some clinical event. Journal of Chronic Diseases 27 (1974) 15–24

    Article  Google Scholar 

  • Good, C.S. (Ed.): The principles and practice of clinical trials. Edinburgh: Churchill Livingstone 1976

    Google Scholar 

  • Gordis, L.: Assuring the quality of questionnaire data in epidemiologic research. American Journal of Epidemiology 109 (1979) 21–24

    Google Scholar 

  • Grady, F.: Designing the report form. In: Good, C.S. (Ed.): The principles and practice of clinical trials. Edinburgh: Livingstone 1976, 60–74

    Google Scholar 

  • Grady, F.: Handling data of trial results. G.S. Good (Ed.): The principles and practice of clinical trials. Edinburgh: Livingstone 1976, 122–128

    Google Scholar 

  • Green, S.B., D.P. Byar: The effect of stratified randomization on size and power of statistical tests in clinical trials. Journal of Chronic Diseases 31 (1978) 445–454

    Article  Google Scholar 

  • Grimshaw, J.J.: Statistical analysis of trial results. C.S. Good (Ed.): The principles and practice of clinical trials. Edinburgh: Livinstone 1976, 129–137

    Google Scholar 

  • Grizzle, J.E.: The case for management research for large field trials. Journal of Chronic Diseases 30 (1977) 257–259

    Article  Google Scholar 

  • Halperin, M., E. Rogot, J. Gurian, F. Ederer: Sample sizes for medical trials with special reference to long-term therapy. Journal of Chronic Diseases 21 (1968) 13–24

    Article  Google Scholar 

  • Harris, E.L., J.D. Fitzgerald (Eds.): The principles and practice of clinical trials. Edinburgh, London: Livingstone 1970

    Google Scholar 

  • Hasskarl, H.: Rechtliche Zulässigkeit der klinischen Prüfung. Deutsches Ärzteblatt 75 (1978) 1087–1094 und

    Google Scholar 

  • Hasskarl, H.: Rechtliche Zulässigkeit der klinischen Prüfung. Deutsches Ärzteblatt 75 (1978) 1150–1155

    Google Scholar 

  • Hasskarl, H., H. Kleinsorge: Arzneimittelprüfung — Arzneimittelrecht. Stuttgart: Gustav Fischer 1979

    Google Scholar 

  • Hawkins, C.F.: Presentation of results. In: C.S. Good (Ed.): The principles and practice of clinical trials. Edinburgh: 1976, 138–146

    Google Scholar 

  • Hölzel, D., K. Überla: Grundsätze der Versuchsplanung. In: H.P. Kuemmerle (Hrsg.): Methoden der klinischen Pharmakologie. München: Urban und Schwarzenberg 1978, 37–57

    Google Scholar 

  • Huskisson, E.C.: Trials of anti-rheumatics drugs. In: C.S. Good (Ed.): The principles and practice of clinical trials. Edinburgh: 1976, 188–194

    Google Scholar 

  • Immich, H.: Praktische Anwendung der Klassifikations- und Codierungsprinzipien. In: S. Koller, G. Wagner (Hrsg.): Handbuch der medizinischen Dokumentation und Datenverarbeitung. Stuttgart: Schattauer 1975, 246–266

    Google Scholar 

  • Jesdinsky, H.J. (Hrsg.): Memorandum zur Planung und Durchführung kontrollierter klinischer Therapiestudien. Schriftenreihe der Deutschen Gesellschaft für Medizinische Dokumentation, Informatik und Statistik. Stuttgart: Schattauer 1978

    Google Scholar 

  • Jesdinsky, H.J.: Planung einer Studie. In: G. Fülgraff, H. Kewitz (Hrsg.): Arzneimittelprüfung durch den niedergelassenen Arzt. Stuttgart: Gustav Fischer 1979, 44–59

    Google Scholar 

  • Jesdinsky, H.J.: Statistische Auswertung.In: G. Fülgraff, H. Kewitz (Hrsg.): Arzneimittelprüfung durch den niedergelassenen Arzt. Stuttgart: Gustav Fischer 1979, 96–123

    Google Scholar 

  • Johnson, F.N., S. Johnson (Eds.): Clinical trials. Oxford: Blackwell 1977

    Google Scholar 

  • Johnson, F.N., S. Johnson: Organisation of clinical trials. In: F.N. Johnson, S. Johnson (Eds.): Clinical trials. Oxford: Blackwell 1977, 36–82

    Google Scholar 

  • Kempthorne, O.: Of what use are tests of significance and tests of hypothesis. Communications of Statistical Theory and Methodology 8 (1976) 763–777

    Article  MathSciNet  Google Scholar 

  • Kempthorne, O.: Why randomize? Journal of Statistical Planning and Inference 1 (1977) 1–25

    Article  MathSciNet  MATH  Google Scholar 

  • Köhler, C.O.: Datenverarbeitungsanlagen. In: S. Koller, G. Wagner (Hrsg.) Handbuch der medizinischen Dokumentation und Datenverarbeitung. Stuttgart: Schattauer 1975a, 93–117

    Google Scholar 

  • Köhler, C.O.: Informationsträger. In: S. Koller, G. Wagner (Hrsg.): Handbuch der medizinischen Dokumentation und Datenverarbeitung. Stuttgart: Schattauer 1975b, 11–28

    Google Scholar 

  • Köpcke, W., K. Überla: Dokumentation und Datenverarbeitung. In: H.P. Kümmerle (Hrsg.): Methoden der Klinischen Pharmakologie. München: Urban & Schwarzenberg 1978, 83–99

    Google Scholar 

  • Koller, S.: Auswertung. In: S. Koller, G. Wagner (Hrsg.): Handbuch der medizinischen Dokumentation und Datenverarbeitung. Stuttgart: Schattauer 1975, 289–317

    Google Scholar 

  • Koller, S., G. Wagner (Hrsg.): Handbuch der medizinischen Dokumentation und Datenverarbeitung. Stuttgart: Schattauer 1975

    Google Scholar 

  • Kuemmerle, H.P. (Hrsg.): Methoden der klinischen Pharmakologie. München: Urban & Schwarzenberg 1978

    Google Scholar 

  • Lawrie, T.D.V., W.S. Hillis, A. Tweddel: Anti-anginal trials. In: C.S. Good (Ed.): The principles and practice of clinical trials. Edinburgh: Lvingstone 1976, 153–162

    Google Scholar 

  • Levy, P.M.: Interpretation of clinical trials. In: F.N. Johnson, S. Johnson (Eds.): Clinical trials. Oxford: Blackwell 1977, 129–146

    Google Scholar 

  • Lewandowski, G.: Rechtliche Voraussetzungen. In: G. Fülgraff, H. Kewitz (Hrsg.): Arzneimittelprüfung durch den niedergelassenen Arzt. Stuttgart: Gustav Fischer 1979, 10–17

    Google Scholar 

  • Liberman, R.: An analysis of the placebo phenomenon. Journal of Chronic Diseases 15 (1961) 761–783

    Article  Google Scholar 

  • Marsh, B.T.: Keeping the trial going: Medical advisers or coordinators: Prescription costs. In: C.S. Good (Ed.): The principles and practice of clinical trials. Edinburgh: Livingstone 1976, 107–114

    Google Scholar 

  • Martini, P., G. Oberhoffer, E. Weite: Methodenlehre der therapeutischklinischen Forschung. Berlin: Springer 1968

    Google Scholar 

  • Maxwell, C.: The significance of significance. Clinical Trials Journal 5 (1968) 1015–1020

    Google Scholar 

  • Maxwell, C.: The choice of design for clinical trials. Clinical Trials Journal 5 (1968) 1139–1143

    Google Scholar 

  • May, W.W.: The composition and function of ethical committees. Journal of Medical Ethics 1 (1975) 23–29

    Article  Google Scholar 

  • McKinlay, S.M.: Pair matching — A reappraisal of a popular technique. Biometrics 33 (1977) 725–735

    Article  Google Scholar 

  • McPershon, K.: Sequential analysis in clinical trials. In: F.N. Johnson, S. Johnson (Eds.): Clinical Trials. Oxford: Blackwell 1977, 108–128

    Google Scholar 

  • Meier, P.: Statistics and medical experimentation. Biometrics 31 (1975) 511–529

    Article  MATH  Google Scholar 

  • Meydrech, E.F., L.L. Kuuper: Cost considerations and sample size requirements in cohort and case-control studies. American Journal of Epidemiology 107 (1978) 201–205

    Google Scholar 

  • Müller-Römer, D.: Arzneimittelrecht von A — Z. Neu-Isenburg/München: Otto Hoffmann 1978

    Google Scholar 

  • Nicholson, P.A.: Budgeting for clinical trials. In: C.S. Good (Ed.): The principles and practice of clinical trials. Edinburgh: Livingstone 1976, 81–86

    Google Scholar 

  • O’Fallon, J.R., S.D. Dubey, D.S. Salsburg, J.H. Edmonson, A. Soffer, T. Colton: Should there be statistical guidelines for medical research papers. Biometrics 34 (1978) 687–695

    Article  Google Scholar 

  • Peto, R., M.C. Pike, P. Armitage, N.E. Breslow, D.R. Cow, S.V. Howard, N. Mantel, K. McPherson, J. Peto, P.G. Smith: Design and analysis of randomized clinical trials requiring prolonged observation of each patient, I. Introduction and design. British Journal of Cancer 34 (1976) 585–612,

    Article  Google Scholar 

  • Peto, R., M.C. Pike, P. Armitage, N.E. Breslow, D.R. Cow, S.V. Howard, N. Mantel, K. McPherson, J. Peto, P.G. Smith: Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II. Analysis and example. British Journal of Cancer 35 (1977) 1–39

    Article  Google Scholar 

  • Pocock, S.J.: The combination of randomized and historical controls in clinical trials. Journal of Chronic Diseases 29 (1976) 175–188

    Article  Google Scholar 

  • Proppe, A.: Datenerfassung. In: S. Koller, G. Wagner (Hrsg.): Handbuch der medizinischen Dokumentation und Datenverarbeitung. Stuttgart: Schattauer 1975, 199–211

    Google Scholar 

  • Revidierte Deklaration von Helsinki:”Empfehlung für Ärzte, die in der biomedizinischen Forschung am Menschen tätig sind”, beschlossen von der 29. Generalversammlung des Weltärztebundes am 10. Oktober 1975 in Tokio, Deutsches Ärzteblatt 72 (1975) 3162–3163

    Google Scholar 

  • Robinson, B.N.: SIR — Scientific Information Retrieval — User’s Manual. SIR Incorp. Evanston. Ill.: 1980

    Google Scholar 

  • Rudnick, S., R.L. Capizzi: The conduct of therapeutic trials in cancer medicine. Seminars in Oncology 4 (1977) 255–258

    Google Scholar 

  • Sachs, L.: Angewandte Statistik. Berlin: Springer 1978 SAS-Institute: SAS User’s Guide. SAS Incorp. Cary N.C.: 1981

    MATH  Google Scholar 

  • Schindel, L.: Placebo and Placeboeffekte in Klinik und Forschung. Arzneimittelforschung 17 (1967) 892–918

    Google Scholar 

  • Schlesselman, J.J.: Sample size requirements in cohort and case-control studies of disease. American Journal of Epidemiology 99 (1974) 381–384

    Google Scholar 

  • Schneidermann, M.A.: The proper size of clinical trials: “Grandma’s Strudel method”. Journal of New Drugs 4 (1964) 3–11

    Google Scholar 

  • Schnieders, B.: Organisatorische Voraussetzunge. In: G. Fülgraff, H. Kewitz (Hrsg.): Arzneimittelprüfung durch den niedergelassenen Arzt. Stuttgart: Gustav Fischer 1979, 18–25

    Google Scholar 

  • Schork, M.H., R. Remington: Determination for sample size in treatment — control comparison for chronic disease studies in which dropout or non-adherence give a problem. Journal of Chronic Diseases 20 (1967) 233–239

    Article  Google Scholar 

  • Schwartz, W.B., G.A. Gorry, J.P. Kasirer, A. Essig: Decision analysis and clinical judgment. American Journal of Medicine 55 (1974) 459–472

    Article  Google Scholar 

  • Selbmann, H.K.: Statistische Auswertungsverfahren in der klinischtherapeutischen Forschung. In: H.P. Kuemmerle (Hrsg.): Methoden der klinischen Pharmakologie. München: Urban und Schwarzenberg 1978, 59–82

    Google Scholar 

  • Selbmann, H.K.: Grenzen und methodische Schwierigkeiten bei multizentrischen Studien. Arzneimittelforschung/Drug Research 28 (1978) 2023–2026

    Google Scholar 

  • Smith, R.N.: Ethical aspects of drug evaluation. In: F.N. Johnson, S. Johnson (Eds.): Clinical Trials. Oxford: Blackwell 1977, 162–175

    Google Scholar 

  • Snell, E.S.: The choice of investigator. In: C.S. Good (Ed.): The principles and practice of clinical trials. Edinburgh: Livingstone 1976, 75–80

    Google Scholar 

  • Sondik, E.J., B.W. Brown, A. Silvers: High risk subjects and the cost of large field trials. Journal of Chronic Diseases 27 (2974) 177–187

    Article  Google Scholar 

  • Staak, M., A. Weiser: Klinische Prüfung von Arzneimitteln -Methodik und Rechtsgrundlagen. Stuttgart: Enke 1978

    Google Scholar 

  • Tancredi, L.R.: The ethics quagmire and random clinical trials. Inquiry 12 (1975) 171–179

    MathSciNet  Google Scholar 

  • Überla, K.: Die biometrische Planung und Auswertung klinischer Prüfungen. In: K.W. von Eickstedt, F. Gross (Hrsg.): Klinische Arzneimittelprüfung. Stuttgart: Gustav Fischer 1975, 137–144

    Google Scholar 

  • Wade, P.: Information retrieval. In: E.L. Harris, J.D. Fitzgerald (Eds.): The principles and practice of clinical trials. London, Edinburgh: Livingstone 1970, 37–40

    Google Scholar 

  • Wagner, G.: Datenkontrolle. In: S. Koller, G. Wagner (Hrsg.): Handbuch der medizinischen Dokumentation und Datenverarbeitung. Stuttgart: Schattauer 1975, 267–288

    Google Scholar 

  • Walter, E. (Hrsg.): Statistische Methoden I, Grundlagen der Versuchsplanung. Berlin: Springer 1970

    Google Scholar 

  • Weinstein, M.C.: Allocation of subjects in medical experiments. New England Journal of Medicine 291 (1974) 1278–1285

    Article  Google Scholar 

  • Wittenborn, J.R. (Ed.): Guidelines for clinical trials of psychotropic drugs. Pharmakopsychiatrie/Neuro-Psychopharmakologie 10 (1977) 205–231

    Google Scholar 

  • World Health Organization: Principles for the clinical evaluation of drugs. Technical Report Series 403, 1968

    Google Scholar 

  • World Health Organization: Guidelines for evaluation of drugs for use in man. Technical Report Series 563, 1975

    Google Scholar 

  • Zelen, M.: The randomization and stratification of patients to clinical trials. Journal of Chronic Diseases 27 (1974) 365–375

    Article  MathSciNet  Google Scholar 

  • Zelen, M.: Aspects of the planning and analysis of clinical trials in cancer. In: J.N. Srivastava (Ed.): A Survey of Statistical Design and Linear Models. Amsterdam: North Holland 1975, 629–646

    Google Scholar 

  • Zelen, M.: Statistical options in clinical trials. Seminars in Oncology 4 (1977) 441–446

    Google Scholar 

Chapter 3

  • Agras, St., G. Marshall: Recruitment for the coronary primary prevention trial. In: H.P. Roth, R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 25 (1979) 688–690

    Google Scholar 

  • Bundesärztekammer (Hrsg.): Prüfung neuer Arzneimittel in der Praxis des niedergelassenen Arztes. Deutsches Ärzteblatt 75 (1978) 2773–2778

    Google Scholar 

  • Croke, G.: Recruitment for the National Cooperative Gallstone Study. In: H.P. Roth, R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 25 (1979) 691–694

    Google Scholar 

  • Dreher, R.: Gründe für nur mangelhafte kontrollierte Therapiestudien in der Rheumatologie. In: ISR (Internationales Institut für wissenschaftliche Zusammenarbeit e.V. Schloß Reisensburg) (Hrsg.): Probleme und Randbedingungen von Therapiestudien, Methodenkolloquium I, Schloß Reisensburg, 27. — 29. April 1978, 112–115

    Google Scholar 

  • Evans, J.T.: Internal monitoring: Patient and study management at the clinic. In: H.P. Roth, R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 25 (1979) 712–716

    Google Scholar 

  • Grimm, R.H., K. Shimoni, W.R. Harlan, E.H. Istes: Evaluation of patient-care protocol use by various providers. New England Journal of Medicine 292 (1975) 507–511

    Article  Google Scholar 

  • Hagans, J.: The design and methodology of cooperative drug trials. Drug Intelligence and Clinical Pharmacy 8 (1974) 531–534

    Google Scholar 

  • Kahn, H.A., H. Leibowitz, J.P. Ganley, M. Kini, Th. Colton, R. Nickerson, T.R. Dawber: Standardizing diagnostic procedures. American Journal of Opthalmology 79 (1975) 768–775

    Google Scholar 

  • Klimt, P., P.C. Canner: Terminating a long-term clinical trial. In: H.P. Roth, R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 29 (1979) 641–646

    Google Scholar 

  • Meier, P.: Terminating a trial — the ethical problem. In: H.P. Roth, R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 25 (1979) 633–640

    Google Scholar 

  • Mowery, R.L., Williams, D.P.: Aspects of clinic monitoring in largescale multiclinic trials. In: H.P. Roth, R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 29 (1979) 717–719

    Google Scholar 

  • Schreml, W.: Diskussion der Methodik von Therapiestudien im Bereich Krebs anhand von zwei Beispielen: Melanom- und Mamma-Carcinom-Studie. In: ISR (Hrsg.): Probleme und Randbedingungen von Therapiestudien, Methodenkolloquium I, Schloß Reisensburg, 27. — 29. April 1978, 43–53

    Google Scholar 

  • Stauch, M.: Herz-Kreislauf-Therapiestudien in USA und in der Bundesrepublik. In: ISR (Hrsg.): Probleme und Randbedingungen von Therapiestudien, Methodenkolloquium I, Schloß Reisensburg, 27.–29. April 1978, 81–86

    Google Scholar 

  • Williams, O.D.: A framework for quality assurance of clinical data. In: H.P. Roth, R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 29 (1979) 700–702

    Google Scholar 

Chapter 4

  • Benkert, O.: Forschungsansätze bei psycho-pharmakologischen Studien. In: ISR (Hrsg.): Probleme und Randbedingungen von Therapiestudien, Methodenkolloqium II. Schloß Reisensburg, 29. — 30. Juni 1978, 65–73

    Google Scholar 

  • Blalock, H.M.: Measurement in the social sciences. Chicago: Aldine 1974

    Google Scholar 

  • Brook, R.H., A. Davies-Avery, S. Greenfield, L.J. Harris, T. Lelak, N.E. Solomon, J.E. Ware: Assessing the quality of medical care using outcome measures: An overview of the method. Medical Care Supplement 15, 1977

    Google Scholar 

  • Brook, R.H., J.E. Ware, A. Davies-Avery, A.L. Stewart, C.A. Donald, W.H. Rogers, K.N. Williams, S.A. Johnston: Conceptualization and measurement of health for adults in the Health Insurance Study: Vol. VIII Overview. Santa Monica, Ca.: Rand R-1987/8 HEW, October 1979

    Google Scholar 

  • CIPS (Collegium Internationale Psychiatriae Scalarum) (Hrsg.): Internationale Skalen für Psychiatrie. Weinheim: Beltz 1981

    Google Scholar 

  • Donald, C.A., J.E. Ware, R.H. Brook, A. Davies-Avery: Conceptualization and measurement of health for adults in the Health Insurance Study: Vol. IV, Social health. Santa Monica, Ca.: Rand R-1987/4 HEW, August 1978

    Google Scholar 

  • Guttentag, M., E.L. Struening (Eds.): Handbook of evaluation research. London: Sage 1975

    Google Scholar 

  • NCHS (National Center of Health Statistics) (Ed.): Clearinghouse on health indexes, Bibliography quarterly since 1973

    Google Scholar 

  • Stewart, A.L., J.E. Ware, R.H. Brook, A. Dvaies-Avery: Conceptualization and measurement of health for adults in the Health Insurance Study: Vol. II, Physical health in terms of functioning. Santa Monica, Ca.: Rand R-1987/2 — HEW, July 1978

    Google Scholar 

  • Ströbel, G.: Einzelprobleme bei Therapiestudien über rheumatische Arthritis und chronische Polyarthritis. In: ISR (Hrsg.): Probleme und Randbedingungen von Therapiestudien, Methodenkolloqium I, Schloß Reisensburg, 29. — 30. Juni 1978, 105–111

    Google Scholar 

  • Ware, J.E., S.A. Johnston, A. Davies-Avery, R.H. Brook: Conceptualization and measurement of health for adults in the Health Insurance Study: Vol. III, Mental health. Santa Monica, Ca.: Rand R-1987/3-HEW, Dezember 1979

    Google Scholar 

  • Ware, J.E., R.H. Brook, A. Davies-Avery, K.N. Williams, A.L. Stewart, W.H. Rogers, C.A. Donald, S.A. Johnston: Conceptualization and measurement of health for adults in the Health Insurance Study: Vol. I, Model of health and methodology. Santa Monica, Ca.: Rand R-1987/1-HEW, May 1980

    Google Scholar 

Chapter 5

  • Bar, Ch. von, G. Fischer: Haftung bei der Planung und Förderung medizinischer Forschungsvorhaben. Neue juristische Wochenschrift 50 (1980) 2734–2740

    Google Scholar 

  • BMFT (Bundesministerium für Forschung und Technologie) (Hrsg.): The Federal Government’s Program on Promoting Research and Development in the Service of Health 1978–1981, Bonn: 1978

    Google Scholar 

  • Chalmers, Th.C.: The ethics of randomization as a decision making technique and the problem of informed consent. USDHEW Report of the 14th annual Conference of Cardiovascular Training Grant Program Directors. National Heart Institute, 1967

    Google Scholar 

  • Chalmers, Th.C.: Randomization of the first patient. Medical Clinics of North-America 59 (1975) 1035–1038

    Google Scholar 

  • Cochrane, A.L.: Effectiveness and efficiency. London: The Nuffield Provincial Hospital Trust, 1972

    Google Scholar 

  • Deutsch, E.: Das Recht der klinischen Forschung am Menschen. Frankfurt: Lang 1979

    Google Scholar 

  • Fletscher, J.C.: Realities of patient consent to medical research. Hastings Center Studies 1 (1973) 39–49

    Article  Google Scholar 

  • Freireich, E.J., E.A. Gehan: The limitations of the randomized clinical trial. In: V.T. de Vita, H. Busch (Eds.): Cancer drug development. New York: Academic Press 1979, 277–310

    Google Scholar 

  • Hasskarl, H., H. Kleinsorge: Arzneimittelprüfung — Arzneimittelrecht. Stuttgart: Gustav Fischer 1979

    Google Scholar 

  • Helmchen, H., B. Müller-Oerlinghausen (Hrsg.): Psychiatrische Therapieforschung. Ethische und juristische Probleme. Berlin, Heidelberg, New York: Springer 1978

    Google Scholar 

  • Lasagna, L.: Problems in publication of clinical trial methodology. In: H.P. Roth, R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 25 (1979) 751–753

    Google Scholar 

  • Levine, R.J., K. Lebacqz: Some ethical considerations in clinical trials. In: H.P. Roth, R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 25 (1979) 728–741

    Google Scholar 

  • Lewandowski, G.: Rechtliche Voraussetzungen. In: G. Fülgraff, A. Kewitz (Hrsg.): Arzneimittelprüfung durch den niedergelassenen Arzt. Stuttgart:Thieme 1979, 10–17

    Google Scholar 

  • Linzbach, M.: Informed consent — Die Aufklärungspflicht des Arztes im amerikanischen und deutschen Recht. Frankfurt: Lang 1980

    Google Scholar 

  • Meinert, C.L.: Toward more definitive clinical trials. Paper prepared for the National Commission on Digestive Diseases through a work group of the Subcommittee on Research — Targeted and Nondirected, 1978

    Google Scholar 

  • Meinert, C.L., B.S. Hawkins: Methodology: The case of improved communications. In: H.P. Roth, R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 25 (1979) 754–757

    Google Scholar 

  • Mosteller, F.: Problems of omission in communications. In: H.P. Roth, R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 25 (1979) 761–766

    Google Scholar 

  • Relman, A.S.: Publications and promotions for the clinical investigator. in: H.P. Roth, R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 25 (1979) 673–678

    Google Scholar 

  • Roth, H.P., R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 25 (1979)

    Google Scholar 

  • Schoolman, H.M.: Retrieving information on clinical trial methodology. In: H.P. Roth, R.S. Gordon (Eds.): Proceedings of the National Conference on Clinical Trials Methodology. Clinical Pharmacology and Therapeutics 25 (1979) 758–760

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internationales Institut für wissenschaftliche Zusammenarbeit e.V., Schloß Reisensburg, Bürgermeister-Joh.-Müller-Str. 1, 8870, Günzburg, Germany

    Sibylle Biefang

  2. Institut für Medizinische Informationsverarbeitung, Statistik und Biomathematik, Ludwig-Maximilians-Universität, Marchioninistr. 15, 8000, München 70, Germany

    Wolfgang Köpcke & Martin A. Schreiber

Authors
  1. Sibylle Biefang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfgang Köpcke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin A. Schreiber
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Biefang, S., Köpcke, W., Schreiber, M.A. (1983). References. In: Manual for the Planning and Implementation of Therapeutic Studies. Lecture Notes in Medical Informatics, vol 20. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-93237-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93237-3_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-11979-1

  • Online ISBN: 978-3-642-93237-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation